{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:31:11Z","timestamp":1758702671134},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VHRM"],"DOI":"10.2147\/vhrm.s68564","type":"journal-article","created":{"date-parts":[[2015,4,12]],"date-time":"2015-04-12T23:43:48Z","timestamp":1428882228000},"page":"229","source":"Crossref","is-referenced-by-count":14,"title":["Alogliptin benzoate for management of type 2 diabetes"],"prefix":"10.2147","author":[{"given":"Yoshifumi","family":"Saisho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,4]]},"container-title":["Vascular Health and Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=24557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:31:26Z","timestamp":1477866686000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/alogliptin-benzoate-for-management-of-type-2-diabetes-peer-reviewed-article-VHRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/vhrm.s68564","relation":{},"ISSN":["1178-2048"],"issn-type":[{"value":"1178-2048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}